Relmada Therapeutics Inc (STU:4E2)
€ 2.8 0.02 (0.72%) Market Cap: 85.40 Mil Enterprise Value: 7.30 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 29/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1